Short- and long-term outcomes after distal pancreatectomy with radiologic infiltration of splenic vessels for pancreatic ductal adenocarcinoma.

Complications Distal pancreatectomy Outcomes Pancreas Splenic vessels

Journal

Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract
ISSN: 1873-4626
Titre abrégé: J Gastrointest Surg
Pays: Netherlands
ID NLM: 9706084

Informations de publication

Date de publication:
Apr 2024
Historique:
received: 07 11 2023
revised: 22 12 2023
accepted: 13 01 2024
medline: 8 4 2024
pubmed: 8 4 2024
entrez: 7 4 2024
Statut: ppublish

Résumé

The effect of radiologic splenic vessels involvement (RSVI) on the survival of patients with pancreatic adenocarcinoma (PAC) located in the body and tail of the pancreas is controversial, and its influence on postoperative morbidity after distal pancreatectomy (DP) is unknown. This study aimed to determine the influence of RSVI on postoperative complications, overall survival (OS), and disease-free survival (DFS) in patients undergoing DP for PAC. A multicenter retrospective study of DP was conducted at 7 hepatopancreatobiliary units between January 2008 and December 2018. Patients were classified according to the presence of RSVI. A Clavien-Dindo grade of >II was considered to represent a major complication. A total of 95 patients were included in the analysis. Moreover, 47 patients had vascular infiltration: 4 had arterial involvement, 10 had venous involvement, and 33 had both arterial and venous involvements. The rates of major complications were 20.8% in patients without RSVI, 40.0% in those with venous RSVI, 25.0% in those with arterial RSVI, and 30.3% in those with both arterial and venous RSVIs (P = .024). The DFS rates at 3 years were 56% in the group without RSVI, 50% in the group with arterial RSVI, and 16% in the group with both arterial and venous RSVIs (P = .003). The OS rates at 3 years were 66% in the group without RSVI, 50% in the group with arterial RSVI, and 29% in the group with both arterial and venous RSVIs (P < .0001). RSVI increased the major complication rates after DP and reduced the OS and DFS. Therefore, it may be a useful prognostic marker in patients with PAC scheduled to undergo DP and may help to select patients likely to benefit from neoadjuvant treatment.

Sections du résumé

BACKGROUND BACKGROUND
The effect of radiologic splenic vessels involvement (RSVI) on the survival of patients with pancreatic adenocarcinoma (PAC) located in the body and tail of the pancreas is controversial, and its influence on postoperative morbidity after distal pancreatectomy (DP) is unknown. This study aimed to determine the influence of RSVI on postoperative complications, overall survival (OS), and disease-free survival (DFS) in patients undergoing DP for PAC.
METHODS METHODS
A multicenter retrospective study of DP was conducted at 7 hepatopancreatobiliary units between January 2008 and December 2018. Patients were classified according to the presence of RSVI. A Clavien-Dindo grade of >II was considered to represent a major complication.
RESULTS RESULTS
A total of 95 patients were included in the analysis. Moreover, 47 patients had vascular infiltration: 4 had arterial involvement, 10 had venous involvement, and 33 had both arterial and venous involvements. The rates of major complications were 20.8% in patients without RSVI, 40.0% in those with venous RSVI, 25.0% in those with arterial RSVI, and 30.3% in those with both arterial and venous RSVIs (P = .024). The DFS rates at 3 years were 56% in the group without RSVI, 50% in the group with arterial RSVI, and 16% in the group with both arterial and venous RSVIs (P = .003). The OS rates at 3 years were 66% in the group without RSVI, 50% in the group with arterial RSVI, and 29% in the group with both arterial and venous RSVIs (P < .0001).
CONCLUSION CONCLUSIONS
RSVI increased the major complication rates after DP and reduced the OS and DFS. Therefore, it may be a useful prognostic marker in patients with PAC scheduled to undergo DP and may help to select patients likely to benefit from neoadjuvant treatment.

Identifiants

pubmed: 38583897
pii: S1091-255X(24)00122-7
doi: 10.1016/j.gassur.2024.01.018
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

467-473

Informations de copyright

Copyright © 2024 Society for Surgery of the Alimentary Tract. Published by Elsevier Inc. All rights reserved.

Auteurs

Gerardo Blanco-Fernández (G)

Facultad de Medicina y Ciencias de la Salud, Universidad de Extremadura, Badajoz, Spain; Department of Surgery, Hospital Universitario de Badajoz, Badajoz, Spain; Instituto Universitario de Investigación Biosanitaria de Extremadura, Badajoz, Spain.

Mario Serradilla-Martín (M)

Department of Surgery, Hospital Universitario Virgen de las Nieves, University of Granada, Granada, Spain. Electronic address: mserradilla@ugr.es.

Fernando Rotellar (F)

Department of Surgery, Clínica Universidad de Navarra, Pamplona, Spain.

Raquel Latorre (R)

Department of surgery. Hospital Universitario de Guadalajara, Guadalajara, Spain.

Isabel Jaén-Torrejimeno (I)

Department of Surgery, Hospital Universitario de Badajoz, Badajoz, Spain.

Elena Muñoz-Forner (E)

Department of Surgery, Hospital Clínico Universitario, Biomedical Research Institute, University of Valencia, Valencia, Spain.

Celia Villodre (C)

Department of Surgery, Hospital General Universitario Dr. Balmis, Alicante, Spain; Instituto de Investigación Sanitaria y Biomédica de Alicante, Alicante, Spain.

Alberto Carabias-Hernández (A)

Department of surgery. Hospital Universitario de Getafe, Getafe, Spain.

Helga K Kälviäinen-Mejía (HK)

Department of Surgery, Hospital Universitario Miguel Servet, Zaragoza, Spain.

Sara Esteban Gordillo (SE)

Department of Surgery, Clínica Universidad de Navarra, Pamplona, Spain.

Roberto de la Plaza (R)

Department of surgery. Hospital Universitario de Guadalajara, Guadalajara, Spain.

Noelia De Armas-Conde (N)

Department of Surgery, Hospital Universitario de Badajoz, Badajoz, Spain.

Marina Garcés-Albir (M)

Department of Surgery, Hospital Clínico Universitario, Biomedical Research Institute, University of Valencia, Valencia, Spain.

Silvia Carbonell Morote (SC)

Department of Surgery, Hospital General Universitario Dr. Balmis, Alicante, Spain; Instituto de Investigación Sanitaria y Biomédica de Alicante, Alicante, Spain.

Alba Manuel-Vázquez (A)

Department of surgery. Hospital Universitario de Getafe, Getafe, Spain.

Alejandro Serrablo (A)

Department of Surgery, Hospital Universitario Miguel Servet, Zaragoza, Spain.

Fernando Pardo (F)

Department of Surgery, Clínica Universidad de Navarra, Pamplona, Spain.

Luis Sabater (L)

Department of Surgery, Hospital Clínico Universitario, Biomedical Research Institute, University of Valencia, Valencia, Spain.

María Paloma Sanz Muñoz (MPS)

Department of surgery. Hospital Universitario de Getafe, Getafe, Spain.

Jose M Ramia (JM)

Department of Surgery, Hospital General Universitario Dr. Balmis, Alicante, Spain; Instituto de Investigación Sanitaria y Biomédica de Alicante, Alicante, Spain; Universidad Miguel Hernández, Alicante, Spain.

Classifications MeSH